Cefprozil is a second-generation cephalosporin antibiotic used as an active pharmaceutical ingredient. Originally developed in 1983 and approved in 1992, it is available as a generic pharmaceutical raw material for manufacturing finished dosage forms.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 92676-86-3
Cefprozil hydrate
pharmaceutical raw material
Cefadroxil monohydrate
pharmaceutical raw material
(2S,2'S)-N,N'-{(1S,3R,4S)-4-[(3-Amino-3-deoxy-alpha-D-threo-hexopyranosyl)oxy]-6-[(6-amino-6-deoxy-alpha-D-glycero-hexopyranosyl)oxy]-5-hydroxycyclohexane-1,3-diyl}bis(4-amino-2-hydroxybutanamide)
pharmaceutical raw material
Lanifibranor
pharmaceutical raw material
Flomoxef sodium
pharmaceutical raw material
3-[[4-[methyl-[2-(4-methyl-1-piperazinyl)-1-oxoethyl]amino]anilino]-phenylmethylidene]-2-oxo-1H-indole-6-carboxylic acid methyl ester
pharmaceutical raw material
(EZ)-cefprozil
pharmaceutical raw material
Cefaclor
pharmaceutical raw material
(6R,7R)-7-[[(2R)-2-amino-2-(4-hydroxyphenyl)acetyl]amino]-8-oxo-3-[(E)-prop-1-enyl]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
WDLWHQDACQUCJR-ZAMMOSSLSA-N
C/C=C/C1=C(N2[C@@H]([C@@H](C2=O)NC(=O)[C@@H](C3=CC=C(C=C3)O)N)SC1)C(=O)O